论文部分内容阅读
目的:探析米非司酮结合甲氨蝶呤治疗宫外孕的疗效。方法:选取2013年4月至2015年12月来该院就诊的80例宫外孕患者进行研究,通过回顾分析法,将其分为对照组与治疗组各40例,对照组主要实施甲氨蝶呤治疗,治疗组主要实施米非司酮结合甲氨蝶呤治疗,对比两组患者治疗后的疗效。结果:治疗组的总有效率为97.45%,不良反应发生率为2.34%,对照组的总有效率为87.56%,不良反应发生率为13.56%,通过两组患者疗效与不良反应发生率比较,治疗组的效果要优于对照组,而不良反应发生率则低于对照组(P<0.05)。结论:对宫外孕患者使用甲氨蝶呤联合米非司酮进行治疗,其效果显著,值得在临床上推广使用。
Objective: To investigate the efficacy of mifepristone combined with methotrexate in the treatment of ectopic pregnancy. Methods: Eighty patients with ectopic pregnancy who visited our hospital from April 2013 to December 2015 were enrolled in this study. According to retrospective analysis, the patients were divided into control group and treatment group with 40 cases each. The control group was mainly methotrexate Treatment, treatment group, the main implementation of mifepristone combined with methotrexate treatment, compared the efficacy of two groups of patients after treatment. Results: The total effective rate of the treatment group was 97.45%, the incidence of adverse reactions was 2.34%, the total effective rate of the control group was 87.56%, the incidence of adverse reactions was 13.56%. By comparing the two groups of efficacy and incidence of adverse reactions, The treatment group was better than the control group, while the incidence of adverse reactions was lower than the control group (P <0.05). Conclusion: The treatment of methotrexate and mifepristone for ectopic pregnancy patients has significant effect and is worth popularizing in clinic.